Alexander J. Kammien

Alexander J. Kammien

Auto-generated profile, based on publicly available information

Alexander J. Kammien

Yale School of Medicine, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in The Spine Journal
Verified
Journal Article
Closed access
PJPeter Y. Joo
Peter Y. Joo
JZJustin R. Zhu
Justin R. Zhu
AKAlexander J. Kammien
Alexander J. Kammien
MGMichael J. Gouzoulis
Michael J. Gouzoulis
PAPaul M. Arnold
Paul M. Arnold
JGJonathan N Grauer
Jonathan N Grauer

22 June 2022 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
MGMichael J. Gouzoulis
Michael J. Gouzoulis
AKAlexander J. Kammien
Alexander J. Kammien
JZJustin R. Zhu
Justin R. Zhu
SGStephen M. Gillinov
Stephen M. Gillinov
JGJonathan N Grauer
Jonathan N Grauer
JGJonathan N Grauer
Jonathan N Grauer
Ehlers Danlos Syndrome (EDS) is a rare connective tissue disorder that results from mutations in collagen genes. Potentially related to laxity and resultant degenerative changes, adult EDS patients may require posterior lumbar fusion (PLF). However, with low numbers, adequately powered outcome studies have been limited. The purpose of this study was to investigate risk of complications, readmissions and reoperations in adult patients with EDS following single-level PLF, A retrospective study using the 2010 to 2020 MSpine Pearldiver dataset was performed. Adult patients undergoing single-level PLF (excluding any with anterior procedures) with and without EDS for which at least 90-day follow up was available were identified. Any cases performed for trauma, tumor, or infection were excluded. Single-level PLF EDS patients were then matched 1:4 with PLF non-EDS patients based on age, sex, and Elixhauser Comorbidity Index (ECI). Rates of ninety-day any, severe, and minor adverse events as well as readmissions were tabulated and compared with chi-square tests. Multivariate logistical regression was then performed (controlling for age, sex, and ECI). Reoperation surgeries over five years were assessed, Kaplan-Meier survival curves generated, and curves of those with and without EDS were compared with log rank test. In total, there were 170,100 single-level PLF case identified, of which 242 (0.14%) had EDS. After matching, there were 957 without EDS and 239 with EDS. On multivariate regression, there were no significant differences in 90-day any, severe, or minor adverse events, or readmissions (p>0.05 for each). Over five years, there were also not significant differences in rates of reoperation (p> 0.05). For EDS patients undergoing PLF, the current study identified similar 90-day adverse events and 5-year reoperation rates compared to those without EDS. These findings may be useful for patient counseling and surgical planning for those with this rare condition.

24 June 2022 in Arthroplasty Today
Verified
Journal Article
Open access
MGMichael J. Gouzoulis
Michael J. Gouzoulis
AKAlexander J. Kammien
Alexander J. Kammien
DCDennis L. Caruana
Dennis L. Caruana
DWDaniel H. Wiznia
Daniel H. Wiznia
JGJonathan N Grauer
Jonathan N Grauer
Hidradenitis suppurativa (HS) is a skin disorder characterized by inflammatory skin lesions that are most commonly in the inguinal and axillary regions. These skin lesions are common sites of bacterial growth and are thus a potential risk factor for infection following procedures such as total hip arthroplasty (THA) or total knee arthroplasty (TKA). Adult patients undergoing THA or TKA for degenerative etiologies were identified from PearlDiver datasets. For THA and TKA, HS patients were matched 1:4 with non-HS patients based on age, sex, and Elixhauser Comorbidity Index. The incidence of 90-day any, severe, minor, and specific adverse events was compiled and compared with multivariate analyses. Five-year revision rates were plotted on Kaplan-Meier survival curves and compared with log-rank tests. For THA, 331,627 patients were identified, of which HS was noted for 481 patients (0.15%). For TKA, 274,161 patients were identified, of which HS was noted for 290 patients (0.11%). Following THA, HS patients had increased odds of wound dehiscence (odds ratio = 2.55, P = .002). Following TKA, HS patients had increased odds of surgical site infection (odds ratio = 1.95, P = .006). All other 90-day adverse events were not significantly different. There was no significant difference in 5-year implant survival in either procedure. HS is a rare but identified comorbidity for those undergoing THA or TKA. Although most 90-day adverse events and 5-year implant survival were similar to those without this condition, specific wound-related issues were elevated by roughly twofold. These findings could help inform patients and surgeons.

11 May 2022 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
AKAlexander J. Kammien
Alexander J. Kammien
AGAnoop R. Galivanche
Anoop R. Galivanche
MGMichael J. Gouzoulis
Michael J. Gouzoulis
JGJonathan N Grauer
Jonathan N Grauer
MMMichael R. Mercier
Michael R. Mercier
JGJonathan N Grauer
Jonathan N Grauer
Postoperative readmissions are a commonly used metric for quality-of-care initiatives, but emergency department (ED) visits have received far less attention despite their substantial impact on patient satisfaction and healthcare spending. The current study described the incidence and timing of ED visits following single-level ACDF, determined predictive factors and reasons for ED utilization, and compared reimbursement for patients with and without ED use. Single-level ACDF procedures from 2010-2020 were identified in PearlDiver using CPT codes. Patients’ age, sex, Elixhauser comorbidity index (ECI) score, region of the country, and insurance coverage were extracted. The incidence, timing, and primary diagnoses for 90-day ED visits and readmissions were determined, as well as total 90-day reimbursement. Variables were compared using univariate analysis and multivariate logistic regression. Out of 90,298 patients, 90-day ED visits were identified for 10,701 (11.9%), with the greatest incidence in postoperative weeks 1-2. Readmissions were identified for 3,325 (3.7%) patients. Independent predictors of ED utilization included younger age (OR 1.25 per 10-year decrease, p<0.001), greater ECI score (OR 1.40 per 2-point increase, p<0.001), and insurance type (relative to Medicare, Medicaid [OR 2.15, p<0.001] and commercial plans [OR 1.14, p=0.004]). In postoperative weeks 1-2, 51% of primary ED diagnoses involved the surgical site, while 23% involved the surgical site in weeks 3-13. Compared to patients without ED visits, those who visited the ED had 65% greater mean 90-day reimbursement (p<0.001). More than three times as many patients in the current study were found to present to the ED than be readmitted within ninety days of surgery. The identified predictive factors and reasons for ED visits can direct attention to high-risk patients and common postoperative issues. Additional postoperative counseling and integrated care pathways may reduce ED visits, thereby improving patient care and reducing healthcare spending.

27 March 2023 in The Spine Journal
Verified
Journal Article
Closed access
PRPhilip P. Ratnasamy
Philip P. Ratnasamy
KRKatelyn E. Rudisill
Katelyn E. Rudisill
MGMichael J. Gouzoulis
Michael J. Gouzoulis
AKAlexander J. Kammien
Alexander J. Kammien
JGJonathan N Grauer
Jonathan N Grauer

19 October 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
GMGwyneth C. Maloy
Gwyneth C. Maloy
AKAlexander J. Kammien
Alexander J. Kammien
LRLee E. Rubin
Lee E. Rubin
JGJonathan N Grauer
Jonathan N Grauer